# NEOGENOMICS INC (NEO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from NEOGENOMICS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/NEO/mda/fy2025/): filed 2026-02-17; accession 0001077183-26-000010 (https://www.sec.gov/Archives/edgar/data/1077183/000107718326000010/neo-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/NEO/mda/fy2024/): filed 2025-02-18; accession 0001077183-25-000028 (https://www.sec.gov/Archives/edgar/data/1077183/000107718325000028/neo-20241231.htm)
- [FY 2023 MD&A](/company/NEO/mda/fy2023/): filed 2024-02-20; accession 0001077183-24-000011 (https://www.sec.gov/Archives/edgar/data/1077183/000107718324000011/neo-20231231.htm)
- [FY 2022 MD&A](/company/NEO/mda/fy2022/): filed 2023-02-24; accession 0001077183-23-000023 (https://www.sec.gov/Archives/edgar/data/1077183/000107718323000023/neo-20221231.htm)
- [FY 2021 MD&A](/company/NEO/mda/fy2021/): filed 2022-02-25; accession 0001077183-22-000017 (https://www.sec.gov/Archives/edgar/data/1077183/000107718322000017/neo-20211231.htm)

Back to /company/NEO/